...
首页> 外文期刊>Cellular Physiology and Biochemistry >miR-184 Inhibits Tumor Invasion, Migration and Metastasis in Nasopharyngeal Carcinoma by Targeting Notch2
【24h】

miR-184 Inhibits Tumor Invasion, Migration and Metastasis in Nasopharyngeal Carcinoma by Targeting Notch2

机译:miR-184通过靶向Notch2抑制鼻咽癌的肿瘤侵袭,迁移和转移

获取原文
           

摘要

Background/Aims A recent study found that dysregulated microRNA-184 (miR-184) is involved in the proliferation and survival of nasopharyngeal carcinoma (NPC). This study aimed to evaluate the detailed mechanisms of invasion, migration and metastasis of NPC cells. Methods Quantitative reverse-transcription PCR (qRT-PCR) and Western blot were used to confirm the expression levels of miR-184 and Notch2. NPC cell invasion and migration were subsequently examined using in vitro cell invasion and wound-healing assays, respectively. MicroRNA (miRNA) target gene prediction databases and dual-luciferase reporter assay were adopted to validate the target genes of miR-184. Results MiR-184 was downregulated in the NPC cell lines. The miR-184 inhibitor increased the number of invading NPC cells, whereas miR-184 mimics inhibited the invasive ability of such cells. The protein level of E-cadherin decreased, whereas those of N-cadherin and vimentin increased in the anti-miR-184 group. This result showed that miR-184 inhibited NPC cell invasion and metastasis by regulating EMT progression. MiRNA target gene prediction databases indicated the potential of Notch2 as a direct target gene of miR-184. Such a notion was then validated by results of dual-luciferase reporter assay. Notably, shRNANotch2 restrained the EMT and partially abrogated the inhibitory effects of miR-184 on EMT progression in NPC cells. Conclusion MiR-184 functions as a tumour-suppressive miRNA targeting Notch2 and inhibits the invasion, migration and metastasis of NPC.
机译:背景/目的最近的一项研究发现,失调的microRNA-184(miR-184)与鼻咽癌(NPC)的增殖和存活有关。这项研究旨在评估NPC细胞侵袭,迁移和转移的详细机制。方法采用定量逆转录PCR(qRT-PCR)和Western blot法检测miR-184和Notch2的表达水平。随后分别使用体外细胞侵袭和伤口愈合测定法检查NPC细胞的侵袭和迁移。采用MicroRNA(miRNA)靶基因预测数据库和双荧光素酶报告基因分析法验证miR-184的靶基因。结果MiR-184在NPC细胞系中被下调。 miR-184抑制剂增加了侵袭的NPC细胞的数量,而miR-184模仿物抑制了这种细胞的侵袭能力。在抗miR-184组中,E-钙粘蛋白的蛋白质水平降低,而N-钙粘蛋白和波形蛋白的蛋白质水平升高。该结果表明,miR-184通过调节EMT进程来抑制NPC细胞的侵袭和转移。 MiRNA靶基因预测数据库表明Notch2作为miR-184的直接靶基因的潜力。然后,通过双荧光素酶报告基因分析的结果验证了这一概念。值得注意的是,shRNANotch2抑制EMT并部分废除了miR-184对NPC细胞EMT进程的抑制作用。结论MiR-184可作为靶向Notch2的肿瘤抑制性miRNA,并抑制NPC的侵袭,迁移和转移。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号